Chemotherapy-induced alopecia is a major problem in clinical oncology. Doxorubicin, a widely used cancer chemotherapy drug, induces disruption of the hair cycle and subsequent alopecia. We show in this report that doxorubicin causes disruption of the hair-follicle-associated blood vessel network resulting in a greatly reduced density of these blood vessels. Dystrophic hair follicles were also observed with abnormal melanogenesis in the mice treated with doxorubicin. Visualization of the effect of doxorubicin on hair-follicle angiogenesis was made possible by the use of transgenic mice in which green fluorescent protein was driven by regulatory elements of the nestin gene (ND-GFP). In these transgenic mice, the hair-follicle stem cells and the follicle structure as well as the blood vessels associated with the hair follicles express ND-GFP. The hair-follicle stem cells did not appear to be affected by doxorubicin, which may explain why hair regrows after chemotherapy. These results suggest that inhibition of hair-follicle-associated angiogenesis by doxorubicin may be an important factor in hair-follicle dystrophy associated with chemotherapy-induced alopecia. The ND-GFP mouse model is thus useful for the study of the role of angiogenesis in the hair-follicle cycle and the effect of drugs on processes associated with chemotherapy-induced alopecia.
INTRODUCTION
Chemotherapy can induce anagen hair follicles to develop abnormalities that are termed hair-follicle dystrophy (Hendrix et al., 2005) . In some cases, chemotherapy induces the ''dystrophic anagen'' response pathway, a prolonged dystrophic anagen, followed by severely retarded follicular recovery. Severe follicular damage induces the dystrophic catagen pathway, and immediate anagen termination, followed by a dystrophic, abnormally shortened telogen and rapid follicular recovery. The C57BL/6J mouse model of cyclophosphamide-induced alopecia was used to define classification criteria for hair-follicle dystrophy including structure and pigmentation of the hair shaft, location, and volume of ectopic melanin granules, distension of the follicular canal, number of TUNEL-labeled keratinocytes in the hair bulb, and neural cell-adhesion molecule immunoreactivity (Hendrix et al., 2005) .
The hair-follicle stem cells appear to reside in the permanent upper portion of the hair follicle, the so-called bulge area (Cotsarelis et al., 1990; Hoffman, 2000; Taylor et al., 2000; Oshima et al., 2001) . We have recently reported (Li et al., 2003; Amoh et al., 2004 Amoh et al., , 2005a ) that nestin, a marker for neural progenitor cells (Lendahl et al., 1990; Zimmerman et al., 1994; Yaworsky and Kappen, 1999) , is also selectively expressed in cells of the hair-follicle bulge. Follicle bulge cells, labeled with nestin-driven green fluorescent protein (ND-GFP) in transgenic mice, behave as hairfollicle stem cells, differentiating to form much of the hair follicle during each hair growth cycle. We subsequently reported that many of the newly formed nestin-expressing blood vessels in the skin originate from the hair follicle, presumably the hair-follicle stem cells during the anagen phase (Amoh et al., 2004) . These blood vessels are labeled in transgenic mice by ND-GFP. The follicular origin of the ND-GFP-expressing vessels is most evident when transplanting ND-GFP-labeled follicles to unlabeled nude mice. After transplantation, fluorescent new blood vessels originate only from the labeled follicles. The vessels from the transplanted ND-GFP follicles responded to presumptive angiogenic signals from healing wounds. The ND-GFP-expressing blood vessels display the characteristic endothelial cell-specific markers CD31 and von Willebrand factor (Amoh et al., 2004) .
Using the ND-GFP mouse to image the hair-follicle stem cells and associated blood vessels, we demonstrate in this report that doxorubicin, a widely used cancer chemotherapy agent, causes inhibition of the ND-GFP-expressing vessels and dystrophy of the hair follicles. The hair-follicle stem cells appear not to be affected by doxorubicin. These studies suggest an important role of hair-follicle-associated blood vessels in maintaining normal hair-follicle structure and function and in chemotherapy-induced alopecia.
RESULTS
Visualization of angiogenesis associated with hair-follicle cycling in ND-GFP-transgenic mice Before depilation (telogen), the ND-GFP-expressing cells were located in the follicular bulge area and blood vessel network. The blood vessel network interconnected hair follicles via their bulge area (Figure 1b) . At day 6 postdepilation (p.d.) (middle anagen), ND-GFP-expressing outerroot sheath cells were growing from ND-GFP-expressing cells located in the follicular bulge area. The ND-GFP-expressing nascent blood vessel network became more extensive in the lower part of the hair follicular bulge area (Figure 1c ). At day 12 p.d. (late anagen), the ND-GFP-expressing cells were located in the follicular bulge area, outer-root sheath, and hair-follicle blood vessel network (Figure 1d ). At day 18 p.d. (catagen), the ND-GFP-expressing cells were located in the follicular bulge area, outer-root sheath, and blood vessel network. The ND-GFP-expressing outer-root sheath cells were undergoing regression and degeneration, and the ND-GFP-expressing blood vessel network diminished (Figure 1e ). Immunohistochemical staining showed that CD31 and GFP fluorescence colocalized in the ND-GFP-expressing blood vessels (Figure 2) .
The ND-GFP-expressing blood vessel total length in the lower part of hair-follicle bulge was significantly longer at day 6, 12, and 18 p.d. (middle and late anagen, and catagen) than in telogen. The ND-GFP-expressing blood vessel length in the upper part of the hair-follicle bulge in anagen and catagen phase was comparable to that in telogen.
The growth of blood vessels in the lower part of the hair-follicle bulge following/during anagen was significant compared to telogen (P40.001) (Figure 3 ). The data represent the mean values7SD.
hair follicle stem cells appeared not to be affected by doxorubicin.
The ND-GFP-expressing blood vessel total length in the lower part of hair-follicle bulge was significantly shorter in the mice treated with doxorubicin than in the control mice treated with NaCl. The ND-GFP-expressing blood vessel length in the upper part of hair-follicle bulge in the mice treated with doxorubicin was comparable to the control mice treated with NaCl. The ND-GFP-expressing blood vessel density in the upper part of the hair-follicle bulge area in doxorubicin-treated mice was 0.59 (70.15) and in NaCltreated mice 0.58 (70.09). The ND-GFP-expressing blood . ND-GFP-expressing blood vessel density during the hair cycle. The skin samples were excised from dorsal skin before depilation (telogen) and at day 3 (early anagen), day 6 (middle anagen), day 12 (late anagen), day 18 (catagen), and day 30 (telogen) p.d. The frozen skin sections were used for measuring the length of ND-GFP-expressing blood vessels. At least five fields were examined for each section, derived from three differential mice per hair cycle stage. The data represent the mean values7SD. *Po0.001, significant compared with the results obtained before depilation (telogen). www.jidonline.org 13 vessel density in the lower part of hair-follicle bulge area in doxorubicin-treated mice was 0.56 (70.08) and in NaCltreated mice 1.16 (70.18). The data represent the mean values þ SD (Po0.001) (Figure 6 ). Frozen sections for TUNEL staining were made from the skin from mice treated with doxorubicin. We could observe apoptotic cells in sebaceous glands. However, we did not observe apoptotic cells in the ND-GFP-expressing dermal blood vessels of the mice treated with doxorubicin.
Furthermore, the ND-GFP-expressing blood vessel density in the upper part of hair-follicle bulge in the mice treated with doxorubicin was comparable to the control mice treated with NaCl ( Figure 6 ). Most importantly, the ND-GFP-expressing blood vessel density in the lower part of hair-follicle bulge was significantly shorter in the mice treated with doxorubicin than in the control mice treated with NaCl ( Figure 5 ). Thus, it appears that doxorubicin does not cause apoptosis in ND-GFP-expressing blood vessels but inhibits the growth of the ND-GFP-expressing blood vessels in the lower part of hair-follicle bulge. Mecklenburg et al. (2000) showed that synchronized hairfollicle cycling in adolescent C57BL/6 mice is associated with substantial angiogenesis. Mecklenburg et al. (2000) also observed that inhibiting angiogenesis with a fumagillin derivative inhibits experimentally induced anagen development in these mice. Yano et al. (2001) observed perifollicular vascularization during the induced adult hair cycle and postnatal hair development. No endothelial proliferation was observed during catagen and telogen (Yano et al., 2001) .
DISCUSSION
Our previous observation suggests that hair-follicle stem cells can form blood vessels that form a dermal interfollicular microvasculature network (Li et al., 2003; Amoh et al., 2004) . In the present study, we visualized the formation of the inter-follicular microvasculature network during hairfollicle cycling using ND-GFP-expressing transgenic mice. The length of ND-GFP-expressing blood vessels increased during depilation-induced anagen development.
Doxorubicin induces disruption of the hair cycle and subsequent alopecia in the ND-GFP model. We showed that doxorubicin caused inhibition of blood vessel growth as well as inhibition of the ND-GFP-expressing outer-root sheath cells. Dystrophic hair follicles were observed in different hair cycle stages. The fact that the hair follicle stem cells were unaffected by doxorubicin may explain why hair grows back after chemotherapy.
These results suggest that doxorubicin causes inhibition of hair-follicle-associated angiogenesis and that this inhibition may play a major role in chemotherapy-induced dystrophy and alopecia. On the other hand, the hair-follicle-derived blood vessels also vascularize tumors implanted in the skin, and this process is also inhibited by doxorubicin (Amoh et al., 2005a, c) . This mouse model is useful for the study of the role of angiogenesis in the hair-follicle cycle as well as in tumors and the effect of chemotherapy drugs on these processes. The model can be used to determine if specific agents, selectively delivered to the hair follicle (Li and Hoffman, 1995) , can accelerate the effects of chemotherapy on hair-follicle angiogenesis and associated dystrophy while still allowing tumor angiogenesis to be inhibited.
MATERIALS AND METHODS

ND-GFP-transgenic mice
Transgenic mice carrying GFP under the control of the nestin second-intron enhancer were used in this study (ND-GFP mice) (Hoffman, 2000; Mecklenburg et al., 2000; Yano et al., 2001; Amoh et al., 2004) . ND-GFP-transgenic mice were originally obtained from Dr G Enikolopov, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) (Mignone et al., 2004) .
Visualization of nestin expression during the hair cycle
ND-GFP mice, with almost exclusively telogen hair follicles, were anesthetized with tribromoethanol (intraperitoneal injection of 0.2 ml per 10 g of body weight of a 1.2% solution) (Amoh et al., 2004) . The mice were depilated with a hot mixture of rosin and beeswax to induce anagen. Skin samples were excised from the dorsal area under anesthesia before depilation (telogen) and at 48 hours, 72 hours, day-6 (middle anagen), day-12 (late anagen), day-18 (catagen) and at day-30 (telogen). The skin samples were divided into two parts, one for fluorescence microscopy and the other for frozen sections. The samples for frozen sections were embedded in tissue-freezing embedding medium and frozen at À801C overnight. Frozen sections 10 mm thick were cut with a CM1850 cryostat (Leica, Deerfield, IL) and were air-dried. The ND-GFP-expressing blood vessel length in the lower part of hair-follicle bulge was significantly shorter in the mice treated with doxorubicin than in the control mice treated with NaCl. The ND-GFP-expressing blood vessel length in the upper part of hair-follicle bulge in the mice treated with doxorubicin was comparable to the control mice treated with NaCl. At least five fields were examined for each section, derived from three different mice. Treatment started 12 days p.d. The data represent the mean values þ SD (*Po0.001). The results of inhibition of vessel length in the lower part of the follicle by doxorubicin were significant compared to the control mice treated with NaCl.
Fluorescence microscopy
Fluorescence microscopy was carried out by using an Olympus IMT-2 inverted microscope (Melville, NY) equipped with a mercury lamp power supply (Amoh et al., 2004) . The microscope had a GFP filter set (Chroma Technology, Rockingham, VT).
Immunohistochemical staining
CD31 was detected in frozen sections with an anti-rat immunoglobulin horseradish peroxidase detection kit (BD Pharmingen, San Diego, CA) following instructions from the manufacturer. The primary antibody used was CD31 mAb (1:50) (CBL1337) (Chemicon, Temecula, CA). Substrate-chromogen 3,3 0 -diaminobenzidine staining was used for antigen staining. The frozen sections were also stained with propidium iodide (Sigma-Aldrich Inc., St Louis, MO) (5 mg/ml in phosphate-buffered saline).
Doxorubicin-induced alopecia
ND-GFP-transgenic mice, 6-8 weeks old, with almost exclusively telogen hair follicles were used (Amoh et al., 2004) . Mice were anesthetized with tribromoethanol for all invasive procedures. The mice were depilated by a hot mixture of rosin and beeswax. The mice were given daily intraperitoneal injections of 5 mg/g of doxorubicin or 0.9% NaCl solution at days 0, 1, and 2 p.d. Samples of dorsal skin were excised at days 7 and 12 and directly observed by light and fluorescence microscopy with epidermis up and dermis down. Skin samples for frozen sections were embedded in tissuefreezing embedding medium and frozen at À801C overnight. Frozen sections 10 mm thick were cut with a Leica CM1850 cryostat, and were air-dried. Angiogenesis was quantified by measuring the length of ND-GFP-expressing blood vessels. All fields at Â 40 or Â 100 magnification were measured. The total length of ND-GFP-expressing nascent blood vessels was calculated. At least five fields were examined for each section, derived from three mice per hair cycle stage. Vessel density was calculated as the mean length of ND-GFPexpressing blood vessels per square millimeter. Each experimental group consisted of five mice.
TUNEL staining
Samples of dorsal skin were excised at days 6 and 12 and embedded in tissue-freezing embedding medium and frozen at À801C overnight. Frozen sections 10 mm thick were cut with a Leica CM1850 cryostat, and air-dried. TUNEL staining was performed with the DermaTACS TM kit according to the manufacturer's instructions (R&D systems, Minneapolis, MN).
Statistical analysis
The experimental data are expressed as the mean7SD. Statistical analysis was performed using the two-tailed Student's t-test.
All animal studies were conducted in accordance with the principles and procedures outlined in the NIH Guide for the Care and Use of Animals under assurance number A3873-1. Animal experiments were approved by the Institutional Animal Care and Use Committee.
